Bioequivalence Study of Levetiracetam Tablet and Intravenous Infusion in Healthy Japanese Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions
Healthy Volunteers
Interventions
DRUG

Levetiracetam

Strength: 100 mg/mL Form: Concentrate for solution for infusion Frequency: Single dose

DRUG

Levetiracetam

Levetiracetam tablets Strength: 500 mg Form: Tablet Frequency: Single dose

Trial Locations (1)

Unknown

London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

UCB Pharma

INDUSTRY